Cannabis and Opioid Use Disorder
ConditionOpioid Use Disorder
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorShanna Babalonis, PhD
About this trial
This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.
Eligibility criteria
Qualifiers
Current opioid use disorder
Disqualifiers
Current medical conditions that require medical management
Trial design
Treatments tested in this trial
- Inhaled vaporized cannabis
- Intransal opioid
Treatment groups
15 Participants
are divided into 2 treatment groupsSponsors and collaborators
Shanna Babalonis, PhD
Lead sponsor
University of Kentucky
Sponsor institution
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov